Thai Union is backing a fundraising for Jellagen to help it develop Collagen Type 0, a collagen biomaterial to be used as a treatment for skin diseases and as a biomaterial for tissue reconstruction.
The funding will enable UK-based Jellagen to provide safety data and prototype validation on its leading soft tissue healing program, bringing it closer to the next steps of human trials and regulatory filing, according to the company.
